<VariationArchive VariationID="411714" VariationName="NM_002890.3(RASA1):c.613_617del (p.Leu205fs)" VariationType="Deletion" Accession="VCV000411714" Version="11" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-07-29" DateCreated="2017-04-17" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="394972" VariationID="411714">
      <GeneList>
        <Gene Symbol="CCNH" FullName="cyclin H" GeneID="902" HGNC_ID="HGNC:1594" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>5q14.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="87311471" stop="87412930" display_start="87311471" display_stop="87412930" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="86690078" stop="86708849" display_start="86690078" display_stop="86708849" Strand="-" />
          </Location>
          <OMIM>601953</OMIM>
        </Gene>
        <Gene Symbol="RASA1" FullName="RAS p21 protein activator 1" GeneID="5921" HGNC_ID="HGNC:9871" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>5q14.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="87267883" stop="87391916" display_start="87267883" display_stop="87391916" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="86564069" stop="86687742" display_start="86564069" display_stop="86687742" Strand="+" />
          </Location>
          <OMIM>139150</OMIM>
          <Haploinsufficiency last_evaluated="2020-04-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RASA1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-04-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RASA1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_002890.3(RASA1):c.613_617del (p.Leu205fs)</Name>
      <CanonicalSPDI>NC_000005.10:87331416:TTATCTTAT:TTAT</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>5q14.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="87331417" stop="87331421" display_start="87331417" display_stop="87331421" variantLength="5" positionVCF="87331416" referenceAlleleVCF="GTTATC" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="86627234" stop="86627238" display_start="86627234" display_stop="86627238" variantLength="5" positionVCF="86627233" referenceAlleleVCF="GTTATC" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>L205fs</ProteinChange>
      <ProteinChange>L28fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_002890.2" sequenceAccession="NM_002890" sequenceVersion="2" change="c.613_617del">
            <Expression>NM_002890.2:c.613_617del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.10" sequenceAccession="NC_000005" sequenceVersion="10" change="g.87331421_87331425del" Assembly="GRCh38">
            <Expression>NC_000005.10:g.87331421_87331425del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.9" sequenceAccession="NC_000005" sequenceVersion="9" change="g.86627238_86627242del" Assembly="GRCh37">
            <Expression>NC_000005.9:g.86627238_86627242del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011650.1" sequenceAccession="NG_011650" sequenceVersion="1" change="g.68088_68092del">
            <Expression>NG_011650.1:g.68088_68092del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_002890.3" sequenceAccession="NM_002890" sequenceVersion="3" change="c.613_617del" MANESelect="true">
            <Expression>NM_002890.3:c.613_617del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_002881.1" sequenceAccession="NP_002881" sequenceVersion="1" change="p.Leu205fs">
            <Expression>NP_002881.1:p.Leu205fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_022650.3" sequenceAccession="NM_022650" sequenceVersion="3" change="c.82_86del">
            <Expression>NM_022650.3:c.82_86del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_072179.1" sequenceAccession="NP_072179" sequenceVersion="1" change="p.Leu28fs">
            <Expression>NP_072179.1:p.Leu28fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001364075.2" sequenceAccession="NM_001364075" sequenceVersion="2" change="c.934-18626_934-18622del">
            <Expression>NM_001364075.2:c.934-18626_934-18622del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA16611862" DB="ClinGen" />
        <XRef Type="rs" ID="1060503441" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_002890.3(RASA1):c.613_617del (p.Leu205fs) AND Capillary malformation-arteriovenous malformation syndrome" Accession="RCV000468716" Version="15">
        <ClassifiedConditionList TraitSetID="52696">
          <ClassifiedCondition DB="MedGen" ID="C1842180">Capillary malformation-arteriovenous malformation syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-01-05" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_002890.3(RASA1):c.613_617del (p.Leu205fs) AND Capillary malformation-arteriovenous malformation 1" Accession="RCV002470865" Version="8">
        <ClassifiedConditionList TraitSetID="5197">
          <ClassifiedCondition DB="MedGen" ID="C4747394">Capillary malformation-arteriovenous malformation 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-05-26" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_002890.3(RASA1):c.613_617del (p.Leu205fs) AND multiple conditions" Accession="RCV002496786" Version="8">
        <ClassifiedConditionList TraitSetID="46926">
          <ClassifiedCondition DB="MedGen" ID="C2751544">Basal cell carcinoma, susceptibility to, 1</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C4747394">Capillary malformation-arteriovenous malformation 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-07-19" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-01-05" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2017-04-17" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">18446851</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24038909</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29891884</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="52696" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="43207" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Capillary malformation-arteriovenous malformation</ElementValue>
                <XRef ID="Capillary+malformation-arteriovenous+malformation/7888" DB="Genetic Alliance" />
                <XRef ID="3994305" DB="NCBI for submitter" />
                <XRef Type="Phenotypic series" ID="PS608354" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Capillary malformation-arteriovenous malformation syndrome</ElementValue>
                <XRef ID="MONDO:0012016" DB="MONDO" />
                <XRef ID="468975" DB="NCBI for submitter" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="11904" />
                <XRef ID="11904" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Capillary malformation-arteriovenous malformation (CM-AVM) syndrome is characterized by the presence of multiple small (1-2 cm in diameter) capillary malformations mostly localized on the face and limbs. Some affected individuals also have associated arteriovenous malformations (AVMs) and/or arteriovenous fistulas (AFVs), fast-flow vascular anomalies that typically arise in the skin, muscle, bone, spine, and brain; life-threatening complications of these lesions can include bleeding, congestive heart failure, and/or neurologic consequences. Symptoms from intracranial AVMs/AVFs appear to occur early in life. Several individuals have Parkes Weber syndrome (multiple micro-AVFs associated with a cutaneous capillary stain and excessive soft-tissue and skeletal growth of an affected limb).</Attribute>
                <XRef ID="NBK52764" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">21348050</ID>
                <ID Source="BookShelf">NBK52764</ID>
              </Citation>
              <XRef ID="137667" DB="Orphanet" />
              <XRef ID="C1842180" DB="MedGen" />
              <XRef ID="MONDO:0012016" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS608354" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="5197" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="652" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Capillary malformation-arteriovenous malformation 1</ElementValue>
                <XRef ID="MONDO:0020783" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CMAVM</ElementValue>
                <XRef Type="MIM" ID="608354" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">CMAVM1</ElementValue>
                <XRef Type="MIM" ID="608354" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9787" />
                <XRef ID="9787" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Capillary malformation-arteriovenous malformation (CM-AVM) syndrome is characterized by the presence of multiple small (1-2 cm in diameter) capillary malformations mostly localized on the face and limbs. Some affected individuals also have associated arteriovenous malformations (AVMs) and/or arteriovenous fistulas (AFVs), fast-flow vascular anomalies that typically arise in the skin, muscle, bone, spine, and brain; life-threatening complications of these lesions can include bleeding, congestive heart failure, and/or neurologic consequences. Symptoms from intracranial AVMs/AVFs appear to occur early in life. Several individuals have Parkes Weber syndrome (multiple micro-AVFs associated with a cutaneous capillary stain and excessive soft-tissue and skeletal growth of an affected limb).</Attribute>
                <XRef ID="NBK52764" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">21348050</ID>
                <ID Source="BookShelf">NBK52764</ID>
              </Citation>
              <XRef ID="137667" DB="Orphanet" />
              <XRef ID="90307" DB="Orphanet" />
              <XRef ID="C4747394" DB="MedGen" />
              <XRef ID="MONDO:0020783" DB="MONDO" />
              <XRef Type="MIM" ID="608354" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="46926" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="380" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Basal cell carcinoma, multiple</ElementValue>
                <XRef ID="Basal+Cell+Carcinoma%2C+Multiple/753" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">BCC1</ElementValue>
                <XRef Type="MIM" ID="605462" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Basal cell carcinoma, susceptibility to, 1</ElementValue>
                <XRef ID="MONDO:0011556" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9303" />
                <XRef ID="9303" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="practice guideline" Abbrev="NCCN, 2023">
                <URL>https://www.nccn.org/professionals/physician_gls/pdf/nmsc.pdf</URL>
                <CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN GuidelinesÂ®) Basal Cell Skin Cancer, 2023</CitationText>
              </Citation>
              <XRef ID="C2751544" DB="MedGen" />
              <XRef ID="MONDO:0011556" DB="MONDO" />
              <XRef Type="MIM" ID="605462" DB="OMIM" />
            </Trait>
            <Trait ID="652" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Capillary malformation-arteriovenous malformation 1</ElementValue>
                <XRef ID="MONDO:0020783" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CMAVM</ElementValue>
                <XRef Type="MIM" ID="608354" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">CMAVM1</ElementValue>
                <XRef Type="MIM" ID="608354" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9787" />
                <XRef ID="9787" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Capillary malformation-arteriovenous malformation (CM-AVM) syndrome is characterized by the presence of multiple small (1-2 cm in diameter) capillary malformations mostly localized on the face and limbs. Some affected individuals also have associated arteriovenous malformations (AVMs) and/or arteriovenous fistulas (AFVs), fast-flow vascular anomalies that typically arise in the skin, muscle, bone, spine, and brain; life-threatening complications of these lesions can include bleeding, congestive heart failure, and/or neurologic consequences. Symptoms from intracranial AVMs/AVFs appear to occur early in life. Several individuals have Parkes Weber syndrome (multiple micro-AVFs associated with a cutaneous capillary stain and excessive soft-tissue and skeletal growth of an affected limb).</Attribute>
                <XRef ID="NBK52764" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">21348050</ID>
                <ID Source="BookShelf">NBK52764</ID>
              </Citation>
              <XRef ID="137667" DB="Orphanet" />
              <XRef ID="90307" DB="Orphanet" />
              <XRef ID="C4747394" DB="MedGen" />
              <XRef ID="MONDO:0020783" DB="MONDO" />
              <XRef Type="MIM" ID="608354" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5414440" SubmissionDate="2022-12-21" DateLastUpdated="2022-12-24" DateCreated="2022-12-24">
        <ClinVarSubmissionID localKey="vcgs/unit_1/hg38_NM_002890_2_RASA1_c_613_617delCTTAT" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002769287" DateUpdated="2022-12-24" DateCreated="2022-12-24" Type="SCV" Version="1" SubmitterName="Victorian Clinical Genetics Services, Murdoch Childrens Research Institute" OrgID="500104" OrganizationCategory="laboratory" OrgAbbreviation="VCGS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-05-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">18446851</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24038909</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29891884</ID>
          </Citation>
          <Comment>Based on the classification scheme VCGS_Germline_v1.1.1, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss-of-function is a known mechanism of disease for this gene. (N) 0107 - This gene is known to be associated with autosomal dominant disease. A second somatic variant is also required for the development of capillary lesions (PMID: 24038909; 29891884). (N) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (exon 2 of 25). (P) 0251 - Variant is heterozygous. (N) 0301 - Variant is absent from gnomAD. (P) 0701 - Comparable variants have very strong previous evidence for pathogenicity. Other variants predicted to cause NMD have been reported as pathogenic in ClinVar. (P) 0802 - Moderate previous evidence of pathogenicity in unrelated individuals. The variant has been previously reported in patients with capillary malformations and has been shown to segregate with disease (ClinVar, PMID: 18446851, 24038909, 29891884). (P) 1208 - Inheritance information for this variant is not currently available. (N) Legend: (P) - Pathogenic, (N) - Neutral, (B) - Benign</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RASA1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_3207</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_002890.2:c.613_617delCTTAT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0020783" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_38</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5443875" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_002890.3:c.613_617del|OMIM:605462;608354" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002785384" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-07-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_002890.3:c.613_617del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="605462" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="608354" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1065905" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2017-04-17">
        <ClinVarSubmissionID localKey="1108069|MedGen:C1842180" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000552997" DateUpdated="2024-02-28" DateCreated="2017-04-17" Type="SCV" Version="7" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-01-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">18446851</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24038909</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 411714). This premature translational stop signal has been observed in individual(s) with capillary malformations (PMID: 18446851). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Leu205Lysfs*4) in the RASA1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RASA1 are known to be pathogenic (PMID: 24038909).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RASA1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000005.9:g.86627234_86627238del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1842180" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14200269</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1065905" TraitType="Disease" MappingType="XRef" MappingValue="C1842180" MappingRef="MedGen">
        <MedGen CUI="C1842180" Name="Capillary malformation-arteriovenous malformation syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5414440" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0020783" MappingRef="MONDO">
        <MedGen CUI="C4747394" Name="Capillary malformation-arteriovenous malformation 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5443875" TraitType="Disease" MappingType="XRef" MappingValue="605462" MappingRef="OMIM">
        <MedGen CUI="C2751544" Name="Basal cell carcinoma, susceptibility to, 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5443875" TraitType="Disease" MappingType="XRef" MappingValue="608354" MappingRef="OMIM">
        <MedGen CUI="C4747394" Name="Capillary malformation-arteriovenous malformation 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

